Patent · US Active

Method to functionalize cells in human blood, other fluids and tissues using nanoparticles

US10391146B2 · kind B2 · utility

0Cited by

0References

10Claims

0Family size

Assignee

Cornell University · IT

Inventors

Michael R. King · Oak Creek, US
Michael J. Mitchell · Las Vegas, US
Kuldeepsinh Rana · Lakewood, US
Elizabeth C. Wayne · Ithaca, US
Chris Schaffer · Fallbrook, US
Siddarth Chandrasekaran · Issaquah, US

Key dates

Filing date	Aug 4, 2014
Grant date	Aug 27, 2019
Priority date	—
Expiry date	Aug 4, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/2896
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and methods for inhibiting metastatic cancer cells. The compositions comprise nanoparticles which have incorporated therein leukocyte adhesion molecules and therapeutic molecules exposed on their surface. The nanoparticles may be provided attached to leukocytes. Introduction of these compositions in to the circulation of individuals results in inhibition and reduction of metastatic cancer cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.